Medall Spark Diagnostics Nashik Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 17-07-2024
- Paid Up Capital ₹ 2.50 Cr
as on 17-07-2024
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 10.04%
(FY 2022)
- Profit 94.46%
(FY 2022)
- Ebitda 40.59%
(FY 2022)
- Net Worth -31.79%
(FY 2022)
- Total Assets -27.22%
(FY 2022)
About Medall Spark Diagnostics Nashik
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Yogeshwaran Nagarajan, Parimal Sonawane, Rohan Kashyape, and One other member serve as directors at the Company.
- CIN/LLPIN
U74120TN2013PTC091043
- Company No.
091043
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 May 2013
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Medall Spark Diagnostics Nashik?
Board Members(4)
Financial Performance and Corporate Structure Insights of Medall Spark Diagnostics Nashik.
Medall Spark Diagnostics Nashik Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 10.04% increase. The company also saw a substantial improvement in profitability, with a 94.46% increase in profit. The company's net worth observed a substantial decline by a decrease of 31.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Medall Spark Diagnostics Nashik?
In 2022, Medall Spark Diagnostics Nashik had a promoter holding of 76.00% and a public holding of 24.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medall Scans And Labs Marthahalli Private Limited
Active 13 years 5 monthsYogeshwaran Nagarajan and Ravi Aggarwal are mutual person
Clumax Diagnostic And Research Centre Private Limited
Active 19 years 10 monthsYogeshwaran Nagarajan and Ravi Aggarwal are mutual person
Medall Scans And Labs Ranchi Private Limited
Active 9 years 3 monthsYogeshwaran Nagarajan and Ravi Aggarwal are mutual person
Medall Visakhapatnam Private Limited
Active 5 years 10 monthsYogeshwaran Nagarajan and Ravi Aggarwal are mutual person
Spark Wellness Private Limited
Active 2 years 3 monthsParimal Sonawane and Rohan Kashyape are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medall Spark Diagnostics Nashik?
Unlock and access historical data on people associated with Medall Spark Diagnostics Nashik, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Jul 11, 2013, Medall Spark Diagnostics Nashik has raised a total of ₹ 4.19 Cr, with the most recent deal valued at ₹ 6 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.